Sub Cat | Host Species | Target Species | Cross Reactivity | |
---|---|---|---|---|
V3S-1124-YC2322 | Human | SARS-CoV-2 | ||
V3S-0623-XY41 | Human | SARS-CoV-2 | MERS-CoV | |
V3S-0623-XY88 | Human | SARS-CoV-2 | ||
V3S-0623-XY9 | Human | SARS-CoV-2 | SARS-CoV-2 variants, SARS-like bat coronavirus |
Description | The antibody Fab14 binds to SARS-CoV-2 spike protein. It can only bind RBD in the up confirmation as, in the down conformation, it would clash with an adjacent RBD domain. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | SARS-CoV-2 |
Epitope | Spike protein |
Isotype | IgG1 |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA, Neut |
Application Notes | The RBD proteins were coated on Corning high binding assay plates with a concentration of 2 μg/ml at 4°C overnight and blocked with 5% skim milk at 37°C for 2 h. Serially diluted antibodies were added at a volume of 100 μl per well for incubation at 37°C for 2 h. The anti_x0002_human IgG Fab2 HRP-conjugated antibody was diluted 1:5000 and added at a volume of 100 μl per well for incubation at 37°C for 1 h. The plates were washed 5 times with PBST between incubation steps. TMB substrate was added 100 μl per well for color development for 3 min and 2 M H2SO4 was added 50 μl per well to stop the reaction. The OD450 was read by a SpectraMax microplate reader with data collected by SoftMax Pro version 6.5.1. The data points were plotted using GraphPad Prism8, and the EC50 values were calculated using a three-parameter nonlinear model. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Western Blot Protocol |
Target | SARS-CoV-2 |
Alternative Name | Severe acute respiratory syndrome coronavirus 2 |
Research Area | Coronavirus Disease 2019 |
Related Disease | Coronavirus Disease 2019 |